United States · FDA National Drug Code directory
Triamcinolone Acetonide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 25021-054_47b34d92-4a8f-449b-8ee9-0ce41c83f851
- Product NDC
- 25021-054
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- Triamcinolone Acetonide
- Labeler
- Sagent Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260301
- Source listing expiry
- 20271231
Source-listed ingredients
- TRIAMCINOLONE ACETONIDE — 40 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL in 1 CARTON (25021-054-01) / 1 mL in 1 VIAL · 25021-054-01
- 1 VIAL in 1 CARTON (25021-054-05) / 5 mL in 1 VIAL · 25021-054-05
- 1 VIAL in 1 CARTON (25021-054-10) / 10 mL in 1 VIAL · 25021-054-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →